NCT03092245View on ClinicalTrials.gov

Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 18, 2017

Primary Completion Date

April 17, 2019

Study Completion Date

April 17, 2019

Conditions
Septic Shock
Interventions
DRUG

OctaplasLG

OctaplasLG is given as an infusion when resuscitation fluids are required.

DRUG

Ringer-Acetate

Ringer-acetate is given as an infusion when resuscitation fluids are required.

Trial Locations (1)

2200

ICU Bispebjerg Hospital, Copenhagen

Sponsors

Collaborators (1)

Octapharma
All Listed Sponsors
collaborator

Octapharma

INDUSTRY

collaborator

University of Iceland

OTHER

lead

Rigshospitalet, Denmark

OTHER